Browsing: FDA

Biomarker discovery BMV guidance-feature-image-bioelectric
0

Part two of the White Paper published in Bioanalysis from the 2019 13th Workshop on Recent Issues in Bioanalysis (WRIB) covers the FDA BMV guidance and the ICH M10 BMV Guideline and Regulatory inputs.

Interviews 3D-cells-purple_RGB
0

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.

1 2 3 13